Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy
Journal of Clinical Investigation (2004) - Comment
pubmed: 15599405  doi: 10.1172/jci22046  doi: 10.1172/jci200422046  issn: 0021-9738 

Jonathan D. Silk, Ian F. Hermans, Uzi Gileadi, Tsung Wen Chong, Dawn Shepherd, Mariolina Salio, Bini Mathew, Richard R. Schmidt, Sarah Jane Lunt, Kaye J. Williams, Ian J. Stratford, Adrian L. Harris, Vincenzo Cerundolo